New Treatment for Asthma - Frankly Speaking EP 46

We will discuss the use of azithromycin as a therapeutic option for patients with persistent symptomatic asthma despite controller maintenance therapy with inhaled corticosteroids and a long-acting bronchodilator.
Guest: Alan Ehrlich MD

This activity is part of the Frankly Speaking with Dr. Frank Domino podcast series.

Credits

0 Credits - Not for CME/CE Credit

Effective Date: 12/11/2017.

Expiration Date: 12/31/2099.

Topics

Healthy Lifestyle

Faculty

Frank J. Domino, MD

Return to Homepage See More Episodes

Resources

Gibon PG et al. Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial. Lancet. 2017 Aug 12;390(10095):659-668
Johnston SL et al. Azithromycin for Acute Exacerbations of Asthma: The AZALEA Randomized Clinical Trial. JAMA Intern Med. 2016 Nov 1;176(11):1630-1637Global Initiative for Asthma.
Global Strategy for Asthma Management and Prevention. Revised 2016. http://ginasthma.org/2016-gina-report-global-strategy-for-asthma-management-and-prevention/.